The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
What is a biotech index?
The index was launched in 1992. It constitutes the top 30 large-cap biotech companies and weights them equally. The index is designed to reflect the performance of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
What is the ice Biotechnology Index?
The ICE Biotechnology Index is a rules-based, modified float-adjusted market capitalization-weighted index that tracks the performance of qualifying U.S. listed biotechnology companies.
